TWIST1 and lung cancer: As an inhibitor of TWIST1, harmine can inhibit the expression and result in the degradation of TWIST1; it was identified as a first-in-class TWIST1 inhibitor with marked antitumor activity in oncogene-driven non–small cell lung cancer (53).